Zobrazeno 1 - 10
of 647
pro vyhledávání: '"Kramer Barnett S"'
Autor:
Cappuccio Antonio, Sonnenschein Carlos, Soto Ana M, Baker Stuart G, Potter John D, Kramer Barnett S
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 89 (2009)
Abstract Background There is experimental evidence from animal models favoring the notion that the disruption of interactions between stroma and epithelium plays an important role in the initiation of carcinogenesis. These disrupted interactions are
Externí odkaz:
https://doaj.org/article/16871665f66742118131bee76f053dc6
Autor:
Xia, Changfa, Basu, Partha, Kramer, Barnett S, Li, He, Qu, Chunfeng, Yu, Xue Qin, Canfell, Karen, Qiao, Youlin, Armstrong, Bruce K, Chen, Wanqing *
Publikováno v:
In The Lancet Public Health December 2023 8(12):e996-e1005
Autor:
Kramer Barnett S, Baker Stuart G
Publikováno v:
BMC Cancer, Vol 7, Iss 1, p 151 (2007)
Abstract Background The prevailing paradigm in cancer research is the somatic mutation theory that posits that cancer begins with a single mutation in a somatic cell followed by successive mutations. Much cancer research involves refining the somatic
Externí odkaz:
https://doaj.org/article/bd958cb977de472488ccabbb87a37a6c
Autor:
Kramer Barnett S, Baker Stuart G
Publikováno v:
BMC Bioinformatics, Vol 7, Iss 1, p 407 (2006)
Abstract Background The goal of most microarray studies is either the identification of genes that are most differentially expressed or the creation of a good classification rule. The disadvantage of the former is that it ignores the importance of ge
Externí odkaz:
https://doaj.org/article/da862cf719194153826b4e40959158f4
Publikováno v:
BMC Medical Research Methodology, Vol 4, Iss 1, p 24 (2004)
Abstract Background There is a common belief that most cancer prevention trials should be restricted to high-risk subjects in order to increase statistical power. This strategy is appropriate if the ultimate target population is subjects at the same
Externí odkaz:
https://doaj.org/article/c68d26505d6743c692363c1979e89922
Autor:
Kramer Barnett S, Baker Stuart G
Publikováno v:
BMC Medical Research Methodology, Vol 3, Iss 1, p 23 (2003)
Externí odkaz:
https://doaj.org/article/bbce00e6b71a47c5b760a888d2a1a49e
Autor:
Kramer Barnett S, Baker Stuart G
Publikováno v:
BMC Medical Research Methodology, Vol 3, Iss 1, p 16 (2003)
Abstract Background There is common belief among some medical researchers that if a potential surrogate endpoint is highly correlated with a true endpoint, then a positive (or negative) difference in potential surrogate endpoints between randomizatio
Externí odkaz:
https://doaj.org/article/f71163d4468742c0a72da2af63029993
Publikováno v:
BMC Medical Research Methodology, Vol 3, Iss 1, p 11 (2003)
Abstract Background When evaluating cancer screening it is important to estimate the cumulative risk of false positives from periodic screening. Because the data typically come from studies in which the number of screenings varies by subject, estimat
Externí odkaz:
https://doaj.org/article/e722ea4fc8414c62938e1101688040bb
Autor:
Kramer Barnett S, Baker Stuart G
Publikováno v:
BMC Medical Research Methodology, Vol 3, Iss 1, p 10 (2003)
Abstract Background Randomized trials stochastically answer the question. "What would be the effect of treatment on outcome if one turned back the clock and switched treatments in the given population?" Generalizations to other subjects are reliable
Externí odkaz:
https://doaj.org/article/0a3d12709ef34fa186d06729446e96a0
Publikováno v:
BMC Medical Research Methodology, Vol 3, Iss 1, p 4 (2003)
Abstract Background Because randomized cancer screening trials are very expensive, observational cancer screening studies can play an important role in the early phases of screening evaluation. Periodic screening evaluation (PSE) is a methodology for
Externí odkaz:
https://doaj.org/article/91ed811f93834cc48a3174b7379283ed